Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FJ77G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,142
Award facts
- Contract value 100% obligated
- $5,141.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors at a firm fixed price ceiling value of $5,141.53. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that authorizes the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products including diabetes medications, neurological treatments, pain management drugs, antibiotics, and specialty medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Zepbound, a GLP-1 receptor agonist used in diabetes and weight management treatment, exemplifies AmerisourceBergen's role in ensuring pharmaceutical supply chain continuity for military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJ77G?
SPE2DR26FJ77G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FJ77G worth?
The government has obligated $5,142 on SPE2DR26FJ77G.
Is contract SPE2DR26FJ77G an order under another contract?
Yes. SPE2DR26FJ77G is a delivery order under SPE2DR25D6039, an indefinite delivery contract.
Was contract SPE2DR26FJ77G competed?
The extent of competition for SPE2DR26FJ77G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award